Comments are off for this post

Cooley Elects 13 New Partners for January 1, 2017

Palo Alto ­­– December 8, 2016 – Thirteen lawyers have been elected to Cooley’s partnership, effective January 1, 2017. They are located across seven of the firm’s offices.

“This is a group of incredibly talented individuals, all of whom share a deep commitment to our clients,” said Joe Conroy, Cooley’s chief executive officer. “I’m proud of these next generation leaders and I am confident they will make lasting contributions to our firm.”

Ben Beerle (San Francisco) – Beerle is a member of Cooley’s M&A group. His practice focuses on M&A, joint ventures, minority investments and other complex corporate transactions, primarily in the technology and life sciences industries. He represents strategic and financial buyers and sellers in public and private acquisitions and has significant cross-border experience. He earned his BA from the University of California, Los Angeles in 2001 and his JD, cum laude, from the University of Michigan Law School in 2007.

Matt Caplan (San Francisco) – Caplan is a member of Cooley’s commercial litigation group. He focuses his practice on trial and appellate litigation, with an emphasis on trade secret, consumer class action and healthcare litigation. He has represented individuals and corporate clients in a variety of litigation and regulatory matters and has participated in multiple trials and arbitrations on their behalf. He earned his BA, with honors, from the University of California, Los Angeles in 2004 and his JD from the University of California, Los Angeles School of Law in 2008.

Sarah diFrancesca (New York) – diFrancesca is a member of Cooley’s healthcare & life sciences regulatory group. She represents life sciences and healthcare companies in connection with federal and state government investigations, inquiries, settlements and voluntary disclosures. She also advises late-stage pre-commercial and commercial pharmaceutical, medical device, biotechnology and clinical laboratory companies on a wide variety of fraud and abuse, compliance and regulatory matters. She earned her BA, cum laude, from Saint Louis University in 2001 and her JD from Saint Louis University School of Law in 2005.

Carlton Fleming (Palo Alto) – Fleming is a member of Cooley’s public companies group. He practices general corporate and securities law, representing high-growth private and public companies in a wide range of matters, including formation and financing activities, corporate governance, public offerings and SEC reporting and compliance. He also represents investment banks and venture capital firms in public offerings and private placements. He earned his BA from Duke University in 2004 and his JD/LLM from Duke University School of Law in 2007.

Seth Gottlieb (Palo Alto) – Gottlieb is a member of Cooley’s emerging companies group. His practice focuses on representing companies, entrepreneurs and venture capital investors in a broad range of corporate transactions, including financing activities, M&A and public offerings. He typically advises companies in the technology, medical device and biotechnology industries. He earned his BA from George Washington University in 2004 and his JD, cum laude, from Santa Clara University School of Law.

Charles Haley (San Diego) – Haley is a member of Cooley’s technology transactions group. He represents public and private companies on all aspects of technology transactions. He regularly counsels clients on application and enterprise software licensing agreements; Software as a Service (SaaS) transactions; software and hardware product development agreements; technology related professional services; and distribution agreements including OEM and VAR transactions. He earned his BA, summa cum laude, from Princeton University in 1991 and his JD from the University of Virginia School of Law in 1995.

Alan Hambelton (Seattle) – Hambelton is a member of Cooley’s public companies group. He represents technology and life sciences companies in corporate and securities matters. He specializes in advising public companies in capital market transactions, reporting and disclosure matters, and corporate governance. He also has extensive experience representing emerging companies in formation, financings, M&A and other strategic transactions. He earned his BA from the University of Washington in 2003 and his JD from the University of Virginia School of Law in 2007.

Jonie Ing Kondracki (San Francisco) – Kondracki is a member of Cooley’s capital markets group. She represents investment banks and issuers in a wide range of public and private equity and debt securities offerings. She also represents public companies with respect to general corporate and securities matters. She earned her BA from the University of California, Berkeley in 2002 and her JD, cum laude, from the University of Pennsylvania Law School in 2007.

Siana Lowrey (San Francisco) – Lowrey is a member of Cooley’s public companies group. She represents clients in a variety of corporate matters, with a particular focus on securities offerings and general corporate representation of high-growth private and public companies. She has substantial experience representing private companies preparing for an initial public offering, guiding them through the IPO process and continuing to counsel them as public companies. She earned her BA from University of California, Los Angeles in 2004 and her JD from University of California, Berkeley School of Law in 2007.

Lowell Mead (Palo Alto) – Mead is a member of Cooley’s IP litigation group. His practice focuses on technology and intellectual property litigation, primarily patent litigation. He has experience litigating patent infringement cases involving a wide range of technologies and has experience litigating other complex disputes in federal and state courts and in arbitration. He earned his BA, with honors, from the University of Chicago in 1998 and his JD, cum laude, from the University of Michigan Law School in 2002.

Phil Mitchell (New York) – Mitchell is a member of Cooley’s healthcare and life sciences regulatory practice. He provides regulatory counsel to a range of clients including hospital systems, provider practice groups, management services organizations, clinical laboratories, managed care organizations and health insurers, pharmaceutical and biologic manufacturers, specialty pharmacies, other proprietary and nonprofit health care enterprises and investment firms. He earned his BA and BS from the University of Pennsylvania in 1982, his JD from the University of Virginia School of Law in 1986 and his MPA from Princeton University in 1987.

Noah Pittard (Colorado) – Pittard is a member of Cooley’s emerging companies group. His practice focuses on the formation and financing of emerging technology companies, as well as counseling emerging companies with respect to M&A, strategic relationships, recapitalizations and general corporate matters. He earned his AB from the University of Georgia in 1997 and his JD from the University of California, Berkley School of Law in 2001.

Adam Pivovar (Washington, DC) – Dr Pivovar is a member of Cooley’s IP litigation group. His practice focuses on patent and technology related litigation. Adam has litigated cases involving a wide range of technologies across the life sciences, biotechnology, medical instruments, software and hardware industries in federal courts, the International Trade Commission and the Patent Trademark and Appeal Board. He earned his BS from the University of Wisconsin-Madison in 1995, his PhD from the University of Minnesota in 2000 and his JD, with honors, from George Washington University Law School in 2006.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has 900 lawyers across 12 offices in the United States, China and Europe.

Comments are closed.